Hepatic artery infusion chemotherapy with systemic capecitabine and camrelizumab for treating unresectable hilar cholangiocarcinoma: An initial investigation of efficacy and safety - Li, Long; Liu, Song; Wang, Qingdong; Wang, Yanhua; Yu, Guangji (Journal of cancer research and therapeutics, 2024)
Keywords: Adult; Aged; Antibodies, Monoclonal, Humanized - administration & dosage; Antibodies, Monoclonal, Humanized - adverse effects; Antibodies, Monoclonal, Humanized - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Bile Duct Neoplasms - drug therapy; Bile Duct Neoplasms - pathology; Cancer; Capecitabine; Capecitabine - administration & dosage; Capecitabine - adverse effects; Capecitabine - therapeutic use; Chemotherapy; Cholangiocarcinoma; Cholangiocarcinoma - drug therapy; Cholangiocarcinoma - pathology; Dosage and administration; Evaluation; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Male; Methods; Middle Aged; Original Article; Retrospective Studies; Survival Rate; Treatment Outcome; China; capecitabine; Camrelizumab; hepatic artery infusion chemotherapy; hilar cholangiocarcinoma